Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Sage Therapeutics Inc

TRADE

NASDAQ: SAGEHealthcare / Biotechnology / USA
168.56-0.06-0.04%Vol 297 0331Y Perf 107.05%
Jul 20th, 2018 16:00
BID168.56 ASK171.00
Open168.78 Previous Close168.62
Pre-Market- After-Trading168.56
 - -%  - -%
Target Price
215.47 
Analyst Rating
Strong Buy 1.04
Potencial %
27.83 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)7 841 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
79.90 
Earnings Date
2nd Aug 2018

Today's Price Range

168.13172.00

 

52wk Range

59.57195.97

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
4.54%
3 Months
13.88%
6 Months
-0.53%
1 Year
107.05%
3 Years
125.68%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
SAGE168.56-0.0600-0.04
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 28.60
Current Ratio 28.90
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 7.38
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -42.20
Cash Flow Per Share -6.08
Price to Tangible Book7.38
Book Value per Share22.77
Enterprise Value (in ths.)6 736 270
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-64.83
ROE last 12 Months -40.33
Return on Assets (5Y Avg) -16.57
ROA last 12 Months -38.21
Return on Capital (5Y Avg) -
ROC last 12 Months -41.80
Return on invested Capital Q -9.72
Return on invested Capital Y-64.01
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-1.85-1.689.19
Q04 2017-2.04-1.7514.22
Q03 2017-1.95-1.97-1.03
Q02 2017-1.67-1.88-12.57
Q01 2017-1.56-1.522.56
Q04 2016-1.14-1.50-31.58
Q03 2016-1.16-1.150.86
Q02 2016-1.04-1.08-3.85
Earnings Per EndEstimateRevision %Trend
6/2018 QR-1.874.59Positive
9/2018 QR-2.182.24Positive
12/2018 FY-8.43-1.08Negative
12/2019 FY-9.52-23.96Negative
Next Report Date2nd Aug 2018
Estimated EPS Next Report-1.84
Estimates Count13
EPS Growth Next 5 Years %4.50
Volume Overview
Volume297 033
Shares Outstanding (in ths.)46 520
Trades Count1 656
Dollar Volume39 537 095
Avg. Volume555 038
Avg. Weekly Volume279 687
Avg. Monthly Volume647 117
Avg. Quarterly Volume529 643

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

61%39%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
11 (91.67 %)
11 (91.67 %)
10 (83.33 %)
Moderate Buy
1 (8.33 %)
1 (8.33 %)
2 (16.67 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.04
Strong Buy
1.04
Strong Buy
1.13

There are no comments yet.

News

x